John Johnson - Jun 1, 2022 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
Director
Signature
John Johnson
Stock symbol
AXGN
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
6/3/2022, 04:14 PM
Previous filing
Dec 20, 2022
Next filing
Jun 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Employee Stock Option (right to purchase) Award $0 +11.8K $0.00 11.8K Jun 1, 2022 Common Stock 11.8K $9.29 Direct F1
transaction AXGN Restricted Stock Units Award $0 +6.46K $0.00 6.46K Jun 1, 2022 Common Stock 6.46K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 1, 2023, one year anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.